With the preliminary report of 94 134 overdose deaths in the US for the 12 months ending on January 1, 2021, it is likely that 2020, in addition to being marred by COVID-19, was also the most deadly drug overdose year on record.1 This unacceptable human toll highlights the urgent need for new strategies to combat the opioid epidemic, particularly as overdoses increasingly involve stimulants and other substances. Building on clinical trials demonstrating the efficacy of medications for opioid use disorder (MOUD), prevailing approaches have emphasized the role of treatment.2 Those approaches remove barriers to treatment, such as expanding treatment coverage and increasing treatment availability with hub-and-spoke models. In these models, treatment seeking, even if influenced by need, predisposing, and enabling factors, is ultimately an individual act.2
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Blanco C, Wall MM, Olfson M. Expanding Current Approaches to Solve the Opioid Crisis. JAMA Psychiatry. 2022;79(1):5–6. doi:10.1001/jamapsychiatry.2021.3136
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.